Feb 2020 swissinfo.ch

Sonov implantThe American subsidiary of Swiss hearing aid firm Sonova expects to shell out up to CHF50 million (around $51 million) in a recall of sub-optimal cochlear implants. The company announced that its US subsidiary Advanced Bionics is conducting a product recall on the initial versions of the HiRes Ultra and Ultra 3D cochlear implant devices. It will retrieve un-implanted devices and replace them with recently approved new versions.  

The company has seen an increase in cases of surgical removal of its implants due to deterioration in hearing performance. However, Sonova claims that less than 0.5% of patients with the implants have needed surgical removal and that the defects do not present a safety issue. The cost of the recall is estimated to be between CHF40 and CHF50 million.   Despite the setback, Sonova expects its Hearing Instruments business to grow by 9 to 11% this year. 

The outbreak of the coronavirus resulted in a one week pause for its Chinese operations. “At this time, this is not expected to materially impact Sonova’s results,” the company said.

Upcoming Events

Mon Tue Wed Thu Fri Sat Sun
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Become a Member

Become a Cicada member
For only A$10 for life, you will receive a copy of Buzz magazine and can attend events.

Latest News

Deafblindness

Here is a link to Deafblindness support and information.
They are based in Western Australia and supported by Senses Australia.

Hear For You logo

 

 

 

Hear For You web site

Vision Statement: “For all young people who are deaf to reach their potential in life.”

Go to top
JSN Boot template designed by JoomlaShine.com
Web Analytics